HALISTER: Gilead to Pay $400 Million for Nimbus’s Liver Disease Drug

Gilead to Pay $400 Million for Nimbus’s Liver Disease Drug

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
GILD US (Gilead Sciences Inc)
1250255D US (Nimbus Therapeutics LLC)

People
Norbert Bischofberger (Gilead Sciences Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283